Paragon 28, Inc. (FNA)

Market Cap	910.88M
Revenue (ttm)	245.00M
Net Income (ttm)	-56.15M
Shares Out	83.72M
EPS (ttm)	-0.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	643,726
Open	10.80
Previous Close	10.66
Day's Range	10.35 - 11.00
52-Week Range	4.65 - 14.79
Beta	1.50
Analysts	Strong Buy
Price Target	15.60 (+43.38%)
Earnings Date	Feb 27, 2025

About FNA

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunio...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 15, 2021
• Employees: 574
• Stock Exchange: NYSE
• Ticker Symbol: FNA
• Website: https://paragon28.com

Financial Performance

In 2023, Paragon 28's revenue was $216.39 million, an increase of 19.30% compared to the previous year's $181.38 million. Losses were -$47.84 million, -28.94% less than in 2022.

Analyst Forecast

According to 5 analysts, the average rating for FNA stock is "Strong Buy." The 12-month stock price forecast is $15.6, which is an increase of 43.38% from the latest price.

Price Target

$15.6

(43.38% upside)

Analyst Consensus: Strong Buy